(Q26852698)

language of work or name

1 reference

December 2013

1 reference

1 reference

24 Suppl 10

1 reference

PubMed

page(s)

x16-21

1 reference

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Genetic analysis of the early natural history of epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Serous carcinogenesis in the fallopian tube: a descriptive classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Incessant ovulation--a factor in ovarian neoplasia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Effect of Screening on Ovarian Cancer Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

Luteinization of the stroma of metastatic cancer involving the ovary and its endocrine significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

7 January 2021

Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

7 January 2021

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

7 January 2021

Recommendations for the reporting of fallopian tube neoplasms

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

7 January 2021

Ovarian enzymatically active stromal cells can be a promoter of ovarian surface epithelial tumor

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

7 January 2021

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

7 January 2021

Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

7 January 2021

Events of reproductive life and the incidence of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

7 January 2021

Grading ovarian serous carcinoma using a two-tier system

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

7 January 2021

Atypical Epithelial Proliferation in Fallopian Tubes in Prophylactic Salpingo-oophorectomy Specimens from BRCA1 and BRCA2 Germline Mutation Carriers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

7 January 2021

Are all pelvic (nonuterine) serous carcinomas of tubal origin?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT463

7 January 2021

Identifiers

DOI

10.1093/ANNONC/MDT463

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24265397

1 reference

Consolidated OpenCitations Corpus – April 2017